updated results from the momentum trial
Published 1 year ago • 172 plays • Length 2:48Download video MP4
Download video MP3
Similar videos
-
1:24
updated results from the momentum study assessing the efficacy of momelotinib in mf
-
1:53
recent updates from the momentum trial and the value of momelotinib for the treatment of mf
-
3:03
an insight into the momentum trial: safety and efficacy of momelotinib for the treatment of mf
-
1:45
ham-ven as salvage treatment for r/r aml: results from the sal-relax trial
-
3:08
welcome to the video journal of hematology & hematological oncology 🎥🩸
-
9:25
mgus diagnosis: a step-by-step approach
-
9:44
an update on the quantum-first trial: quizartinib plus chemotherapy in flt3-mutated aml
-
5:00
diagnosing and treating al amyloidosis: a 2020 update from dr morie gertz
-
2:43
gemtuzumab ozogamicin in frontline aml therapy
-
0:42
talquetamab treatment in patients with r/r myeloma with prior exposure to t-cell-directed therapies
-
2:18
efficacy and safety results from the anchor trial
-
2:14
long-term follow-up results from the rathl trial: response-adapted treatment for advanced stage hl
-
1:20
overview & updates on the momentum trial comparing momelotinib and danazol in myelofibrosis
-
2:12
results from a phase i trial of tinostamustine in patients with r/r classical hl
-
1:24
mm-6 study: in-class transition to a regimen of ixazomib, lenalidomide, & dexamethasone for myeloma
-
3:17
pet imaging to predict treatment outcomes: follow-up from the echelon-2 trial
-
1:27
insights into the reveal trial: the efficacy of ruxolitinib for the treatment of patients with pv
-
0:59
developing lsc-targeting agents in aml: progress and current therapeutic capacity
-
1:31
ongoing trials in aml and hr-mds: enhance, enhance-2 and enhance-3
-
4:13
benefit trial: isatuximab, lenalidomide, and dexamethasone /- bortezomib in newly diagnosed myeloma
-
1:33
sequencing and the management of adverse events when administering bispecifics for myeloma